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Conclusion: These initial results indicate that aden-
oviruses are a signiﬁcant cause of respiratory disease among
children under ﬁve. Specimen collection is on-going, and
future results will further clarify the epidemiology of ade-
novirus disease in Kenya. Subtyping of the isolates will be
determined by PCR and reported.
doi:10.1016/j.ijid.2008.05.813
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Background: Photodynamic therapy utilizes a photosen-
sitizer, which upon excitation, emits energy that could be
transduced by surrounding molecular oxygen to produce rad-
ical oxygen species. Interaction between the singlet oxygen
species and viruses may have a virucidal effect. In this study,
the potential of using a novel photodynamic system to inac-
tivate enveloped virus was investigated.
Methods: The photosensitizer used was zinc-
phthalocyanine (ZnPC), which was absorbed onto a
novel two-photon nanotransducer (NaYF4) that is activated
by near infrared light (NIR). Dengue 2 virus was mixed with
different concentrations of nanoparticles and exposed to
a NIR light source at varying distances (5 cm and 10 cm)
and durations (5minutes and 10minutes). The amount
of surviving viruses was analyzed using plaque assay and
compared with untreated virus samples. Further photo-
inactivation study is being done on dengue 2 virus-infected
HepG2 cells using nanoparticles that were conjugated with
antibodies speciﬁc for the dengue virus envelope protein.
The infected cells were incubated with the antibody-
conjugated nanoparticles (4 to 110g/mL) and subjected
to NIR illumination (10 cm for 5minutes).
Results: The level of virus inactivation increased with
higher nanoparticle concentrations and at shorter distance
and longer illumination from the NIR source. At all con-
ditions, virus inactivation was complete when 2.2mg/mL
nanoparticles were used and at 44g/mL, virus titer was
reduced by more than 50%. Conjugation with antibody may
enhance the localization of the photo-inactivation site to
targeted viruses or to virus-infected cells only, as shown
by electron and laser scanning confocal microscopy. In
addition, cell viability (MTT) assay showed that the photo-
bleaching effect by NIR light on HepG2 cells was only
minimal.
Conclusion: Given its effectiveness in eradicating virus
activity and its non-cytotoxic effect on cells, photodynamic
therapy using NIR light could be a feasible novel technology
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Background: Since 2002, increasing incidence of aman-
tadine resistance has been detected worldwide. In a minor
extent, emergence of oseltamivir-resistant strains has been
identiﬁed during 2007/2008 winter season. This study aims
to contribute to global surveillance on antiviral resistance
and to risk assessment of drug use with continuous liber-
ation of national data. Its main objective is to evaluate
inﬂuenza virus susceptibility to oseltamivir and amantadine
during 2004/2005—2007/2008, in Portugal.
Methods: Susceptibility to oseltamivir was eval-
uated by ﬂuorescence assay in 233 strains from
2004/2005—2007/2008. NA and HA1 gene sequencing
was performed in statistical outliers and in 30% of sus-
ceptible strains, identiﬁed by ﬂuorescence. Resistance to
amantadine was evaluated by pyrosequencing in 128 strains
from 2004/2005—2006/2007.
Results: All 89 A(H3N2) and 94 B inﬂuenza strains
tested shown to be oseltamivir-susceptible. Of the 50
A(H1N1) strains tested, 3 of the 14 from 2007/2008
were drug-resistant by exhibiting ﬂuorescence-IC50 values
approximately 400 times higher than the median value and
mutation H274Y in NA sequence. Susceptibility to aman-
tadine was detected in all 23 A(H1N1) strains tested.
Resistance was found, by identiﬁcation of mutation S31N in
M2 sequence, in 24 of the 105 A(H3N2) strains tested: in the
single strain from 2005/2006 and in 23 of the 35 strains from
2006/2007.
Discussion: The origin of oseltamivir-resistant A(H1N1)
strains in Portugal (2007/2008), and concurrently in other
European countries, remains unclear. Their persistence
through inﬂuenza seasons and their effect in viral evolution
could become clearer with subsequent and continuous data
analysis. Conversely, emergence of amantadine resistance
in Portugal, identiﬁed in 2005/2006 and persistent through
2006/2007, probably derived from global spread of A(H3N2)
virus bearing mutation S31N. These preliminary ﬁndings can
presently contribute to monitor international dispersion of
resistant viruses. Continuous and timely input of national
data onto global surveillance constitutes the basis for risk
assessment on antiviral drug use.
doi:10.1016/j.ijid.2008.05.815
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Background: Recently, there has been a marked resur-
gence of Dengue Fever (DF) in Singapore. More adults with
chronic diseases including patients on antithrombotic ther-
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apy (ATT) develop DF, dengue haemorrhagic fever (DHF) and
dengue shock syndrome (DSS). We performed a retrospective
review of the management of DF, DHF and DSS in patients
receiving ATT.
Methods: Files with a discharge code of DF from Novem-
ber 2002 to October 2007 were matched with individuals
on ATT. Each case was examined for clinical features con-
sistent with concurrent DF and ATT. Cases were accepted
only if they had fever, haemoconcentration, fall and rise in
platelets, and a positive conﬁrmatory Dengue assay (dengue
IgM or antigen).
Results: 55 individuals were identiﬁed. 45 patients were
excluded because of inconsistent clinical features (9),
non-concurrent ATT (27), unavailable ﬁles (1), lack of con-
ﬁrmatory dengue assay (8). Ten patients were accepted.
All received warfarin. 4 had mechanical prosthetic heart
valve; 3 had atrial ﬁbrillation; 1 had ischemic cardiomy-
opathy; 1 had recurrent pulmonary embolism; 1 had severe
peripheral vascular disease. 9 patients had positive conva-
lescent dengue IgM; 1 had positive dengue antigen. 7 had
DF, 2 had DHF, 1 had DSS. On admission, median platelet
counts was 87,000/mm3 (range 55,000—195,000/mm3);
median INR 1.66 (range 1.10—2.87). 7 patients had their
warfarin discontinued. 4 received platelets for throm-
bocytopaenia (< 29,000/mm3); 3 received vitamin K; 2
received fresh frozen plasma (FFP). 3 patients continued
their warfarin as they were not over-anticoagulated and
had no bleeding complications. None developed throm-
botic complications. Warfarin was restarted when platelets
exceeded 42,000/mm3. The median nadir platelet count was
33,000/mm3 (7,000—95,000/mm3).
Conclusion: Temporary discontinuation of anticoagula-
tion treatment may be necessary in patients with DF, DHF
or DSS. This was not associated with thrombotic events.
Correction of thrombocytopenia and coagulopathy is recom-
mended in the presence of haemorrhage.
doi:10.1016/j.ijid.2008.05.816
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Intruduction: Inﬂuenza is a viral disease of the upper
respiratory tract and has a high prevalence in autumn
and winter. Although inﬂuenza medical treatment has
improved, but a considerable rate of mortality (especially
in high risk group) occur each year during the inﬂuenza
epidemics. Inﬂuenza vaccination rate in high risk group
is very low (<5%). It sounds that lack of knowledge or
attention to inﬂuenza prevention and management in our
physicians.
Method & Materials: A questionnaire was distributed to
a random sampling of general practitioners and medical
students in three teaching hospitals of Mazandaran Univer-
sity of medical science. Questions were asked regarding,
general information about inﬂuenza, treatment, current
use of inﬂuenza vaccines, medical prevention, and knowl-
edge regarding avian inﬂuenza. Answers were scored as
correct based on published literature and CDC recom-
mendations. The data were statistically analyzed using
SPSS(ver,10) and we use Chi-square to compare two
groups.
Results: The knowledge level of medical students and
general practitioners regarding ﬂue and vaccination indi-
cations was comparable. The majority of physicians were
not aware of the severity of inﬂuenza infection in young
children, could not correctly identify all contraindications
to receiving vaccination and their knowledge regarding
chemoprophylaxis was not acceptable. However, on medi-
cal treatment and prevention general physicians had higher
level of knowledge (p < 0.01), while medical students were
better in avian inﬂuenza (p < 0.001).
doi:10.1016/j.ijid.2008.05.817
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The problem of infectious mononucleosis (IM) is very
important today due to the increase of morbidity in Ukraine,
the variety and variability of clinical manifestations, depres-
sion of immunity and ability of turning into a chronic form
of Epstein-Barr virus infection (EBV-infection). To charac-
terize the frequency of transition into a chronic form of
EBV-infection 100 patients with acute IM (45 male and 55
female), aged 17—45, were analyzed, serologically and clin-
ically, during 5 years period (2002—2007).
Typical clinical manifestations with moderate course
were detected in 84% of patients with next clinical ﬁndings:
fever, the symptoms of general intoxication, pharyngitis,
lymphadenopathy, hepatomegaly, splenomegaly, lympho-
cytosis, monocytosis and atypical large cells. Clinical
course had prominent features: acute beginning of dis-
ease, frequent cases of rash, frequent ﬁndings of different
microbes’ associations from nasopharynx, increased number
of patients with diffuse lesions of the liver. 73,0% of investi-
gated had the chronic diseases of respiratory tract, 48,0% -
involvement of digestive tract, 21% - involvement of urino-
genital system, 18,0% - endocrine system, 6,0% - nervous
system, 25,0% of investigated - allergic reactions in medical
history. Chronic somatic diseases were registered in 78,0% of
investigated, which statistically had inﬂuence on the clinical
course severity.
During the dynamic follow-up of patients with chronic IM
it was showed that in a group of patients clinical and labo-
ratory signs of EBV-infection still remained: at the patient’s
discharge from the hospital - 55,0%, after 1 year - 83,0%,
in two years - 76,0%, in three years - 50,0%, in ﬁve years -
28,1%.
In the long-term follow-up (5 years) next forms of chronic
EBV-infection were registered: latent form - 25,6%, reacti-
vation - 46,3%, chronic effaced form - 28,1%, chronic active
form - 9,7%. Received data indicate that long-term follow-up
of patients with chronic EBV infection is necessary and can
